Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arrowhead Pharma (NQ: ARWR )

68.71 USD -0.32 (-0.46%)
Streaming Delayed Price Updated: 9:53 AM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51,850
Open 69.60
Bid (Size) 68.67 (1)
Ask (Size) 68.92 (1)
Prev. Close 69.03
Today's Range 68.42 - 70.78
52wk Range 30.83 - 92.60
Shares Outstanding 103,792,410
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results 
From Business Wire News Releases
Arrowhead Announces ARO-DUX4 as First Muscle Targeted RNAi Candidate Using TRiMTM Platform
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced ARO-DUX4 as Arrowhead’s first muscle targeted investigational RNAi therapeutic candidate to utilize its proprietary Targeted RNAi Molecule... 
From Business Wire News Releases

Performance

YTD
-8.18%
-8.18%
1 Month
-2.54%
-2.54%
3 Month
-17.65%
-17.65%
6 Month
+21.14%
+21.14%
1 Year
+87.63%
+87.63%

More News

Read More
Arrowhead Pharmaceuticals Files IND to Begin Phase 2b Study of ARO-APOC3 in Patients with Severe Hypertriglyceridemia
From Business Wire News Releases
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Arrowhead Pharmaceuticals, Inc. for Potential Breach of Fiduciary Duty Claims
From GlobeNewswire News Releases
Arrowhead Pharmaceuticals Larger Than S&P 500 Component Leggett & Platt
Tags Stocks
From Market News Video
Arrowhead Pharmaceuticals Reports Fiscal 2021 First Quarter Results
From Business Wire News Releases
Arrowhead Pharmaceuticals is Now Oversold (ARWR)
Tags Stocks
From Market News Video
Arrowhead Pharmaceuticals Files IND for Phase 2b Study of ARO-ANG3 for Treatment of Mixed Dyslipidemia
From Business Wire News Releases
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 First Quarter Results
From Business Wire News Releases
First Week of ARWR April 16th Options Trading
Tags Stocks
From Market News Video
Notable Friday Option Activity: FORM, VEEV, ARWR
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.